Ena Respiratory

Melbourne, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

$22.4M raised

Oct 2025

Series B

Biotechnology Health Diagnostics Medical

Top Investors

Bill & Melinda Gates FoundationBrandon CapitalUniseedU.S. Department of DefenseHostplus

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ena Respiratory

How much funding has Ena Respiratory raised?

Ena Respiratory has raised $22.4M in total funding. The most recent round was Series B. The last funding was announced in October 2025.

Who are Ena Respiratory's investors?

Ena Respiratory's investors include Bill & Melinda Gates Foundation, Brandon Capital, Uniseed, U.S. Department of Defense, Hostplus.

Where is Ena Respiratory headquartered?

Ena Respiratory is headquartered in Melbourne, Australia.

What does Ena Respiratory do?

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

What stage is Ena Respiratory at?

Ena Respiratory is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 22, 2025.

MLA

"Ena Respiratory — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/ena-respiratory. Accessed June 4, 2026.

APA

VCBacked. (2025). Ena Respiratory — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ena-respiratory

Wikipedia (cite web)

{{cite web |title=Ena Respiratory — Funding & Investors |url=https://www.vcbacked.co/company/ena-respiratory |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 22, 2025.

Similar Companies in Biotechnology